AIFF · Firefly Neuroscience, Inc.
$1.02
-0.01 (-0.49%)
At close · Aug 27
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company's recurring losses, negative cash flows from operating activities, and revenue that remains insufficient to cover operating costs raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued. ... Because critical elements of these plans are not within management's control, management does not consider them probable of being effectively implemented such that they would alleviate the substantial doubt described above. Accordingly, management has concluded that substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued has not been alleviated.”View the 10-Q filed Aug 11, 2026
Market Cap
$16.00M
Shares
15.69M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Greg Lipschitz | Chief Executive Officer | $1,063,718 |
| David DeCaprio | President and Chief Operating Officer | $748,335 |
| Gil Issachar | Former Chief Technology Officer | $258,986 |
| Paul Krzywicki | Chief Financial Officer | $225,204 |
| Jon Olsen | Former Chief Executive Officer | $44,908 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Gil Issachar | Chief Technology Officer | $803,967 |
| Jon Olsen | Former Chief Executive Officer | $742,968 |
| Greg Lipschitz | — | $262,119 |
| Paul Krzywicki | Chief Financial Officer | $154,962 |
| Samer Kaba | Former Chief Medical Officer | $139,515 |
| Dave Johnson | Former Executive Chairman | $72,500 |
| Scott Reeves | — | $34,950 |
| Stephen Purcell | Former Chief Financial Officer | $16,497 |
| Stella Vnook | — | — |
| David DeCaprio | — | — |
| Brian Posner | — | — |
| Arun Menawat | — | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Gil Issachar | Chief Technology Officer | $192,869 |
| Jon Olsen | Former Chief Executive Officer | $168,380 |
| Stephen Purcell | Former Chief Financial Officer | $121,184 |
| David DeCaprio | — | — |
| Scott Reeves | — | — |
| Brian Posner | — | — |
| Stella Vnook | — | — |
| Arun Menawat | — | — |
| Greg Lipschitz | — | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Timothy G. Hannon | Chief Financial Officer | $792,413 |
| Jon Olsen | Chief Executive Officer | $414,042 |
| G. James Benoit | Chief Executive Officer | $299,192 |
| Stephen Purcell | Former Chief Financial Officer | $268,350 |
| Greg Lipschitz | — | — |
| David DeCaprio | — | — |
| Scott Reeves | — | — |
| Arun Menawat | — | — |
| Stella Vnook | — | — |
| Brian Posner | — | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| G. James Benoit | Chief Executive Officer | $1,648,133 |
| Stanley A. Reese | Chief Executive Officer from January 1, 2021 through August 26, 2021 | $336,928 |
| Matthew T. Sands | Chief Financial Officer from April 22, 2020 through September 29, 2021 | $201,378 |
| Timothy G. Hannon | Chief Financial Officer | $86,136 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stanley A. Reese | Chief Executive Officer from January 1, 2021 through August 26, 2021 | $230,852 |
| Matthew T. Sands | Chief Financial Officer from April 22, 2020 through September 29, 2021 | $190,851 |
| G. James Benoit | Chief Executive Officer | — |
| Timothy G. Hannon | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Arun Menawat | Class III director | Appointed | 2026-08-07 |
| Gil Issachar | Head of AI and Neuroscience | Appointed | 2026-06-22 |
| David DeCaprio | President and Chief Operating Officer | Appointed | 2025-04-24 |
| Greg Lipschitz | Chief Executive Officer | Appointed | 2025-04-01 |
| Arun Menawat | Chairman of the Company | Appointed | 2025-03-12 |
| Greg Lipschitz | Executive Chairman | Resigned | 2025-03-12 |
| Greg Lipschitz | Interim Chief Executive Officer | Appointed | 2025-01-06 |
| Jon Olsen | Chief Executive Officer | Terminated | 2025-01-06 |
| Jon Olsen | member of the board of directors | Resigned | 2025-01-06 |
| Samer Kaba | Chief Medical Officer | Resigned | 2024-12-23 |
| Greg Lipschitz | Executive Chairman | Appointed | 2024-12-03 |
| David Johnson | director of the board of directors | Resigned | 2024-12-03 |
| David Johnson | Executive Chairman | Resigned | 2024-12-03 |
| Stella Vnook | Board | Appointed | 2024-08-20 |
| David Johnson | Executive Chairman of the Board | Appointed | 2024-08-20 |
| Samer Kaba | Chief Medical Officer | Appointed | 2024-08-12 |
| Greg Lipschitz | directors of the Board | Appointed | 2024-08-12 |
| Brian Posner | directors of the Board | Appointed | 2024-08-12 |
| Jon Olsen | directors of the Board | Appointed | 2024-08-12 |
| David DeCaprio | directors of the Board | Appointed | 2024-08-12 |
| Arun Menawat | directors of the Board | Appointed | 2024-08-12 |
| Paul B. Becker | members of the WaveDancer Board | Resigned | 2024-08-12 |
| Bonnie K. Wachtel | members of the WaveDancer Board | Resigned | 2024-08-12 |
| James C. DiPaula, Jr. | members of the WaveDancer Board | Resigned | 2024-08-12 |
| William H. Pickle | members of the WaveDancer Board | Resigned | 2024-08-12 |
Key facts
CIK
803578
CUSIP
317970101
13F (30d)
19 filings
19 filers
Visit website
Investor relations